Derebail, V.K., Nachman, P.H., Key, N.S., Ansede, H., Falk, R.J., Rosamond, W.D. and Kshirsagar, A.V. (2011) Variant Hemoglobin Phenotypes May Account for Differential Erythropoeisis-Stimulating Agent Dosing in African-American Hemodialysis Patients. Kidney International, 80, 992-999.
http://dx.doi.org/10.1038/ki.2011.247

has been cited by the following article:

• TITLE: Sickle Cell Trait, Hemoglobin Levels and Anemia among Black Patients with Predialysis Chronic Kidney Disease: A Post Hoc Analysis

  AUTHORS: F. B. Lepira, T. K. Mukendi, F. I. N. Mbutiwi, J. R. Makulo, E. K. Sumaili, P. K. Kayembe, N. M. Nseka

  KEYWORDS: Anemia, Sickle Cell Trait, Chronic Kidney Disease, Black Africans

  JOURNAL NAME: World Journal of Cardiovascular Diseases, Vol.6 No.8, August 11, 2016

  ABSTRACT: Objective: To assess the relationship between SCT, hemoglobin levels and anemia in CKD black patients. Method: A post-hoc analysis of data from 188 patients, enrolled in a cross-sectional study of sickle cell trait (SCT) and chronic kidney disease (CKD), was performed to assess the relationship between SCT, hemoglobin (Hb) levels and anemia defined as Hb